• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔积液的诊断与治疗建议。更新版。

Recommendations of diagnosis and treatment of pleural effusion. Update.

作者信息

Villena Garrido Victoria, Cases Viedma Enrique, Fernández Villar Alberto, de Pablo Gafas Alicia, Pérez Rodríguez Esteban, Porcel Pérez José Manuel, Rodríguez Panadero Francisco, Ruiz Martínez Carlos, Salvatierra Velázquez Angel, Valdés Cuadrado Luis

机构信息

Servicio de Neumología, Fundación Investigación, Hospital Universitario 12 de Octubre, CIBERES, Madrid, España.

Servicio de Neumología, Hospital Universitario La Fe, Valencia, España.

出版信息

Arch Bronconeumol. 2014 Jun;50(6):235-49. doi: 10.1016/j.arbres.2014.01.016. Epub 2014 Mar 31.

DOI:10.1016/j.arbres.2014.01.016
PMID:24698396
Abstract

Although during the last few years there have been several important changes in the diagnostic or therapeutic methods, pleural effusion is still one of the diseases that the respiratory specialist have to evaluate frequently. The aim of this paper is to update the knowledge about pleural effusions, rather than to review the causes of pleural diseases exhaustively. These recommendations have a longer extension for the subjects with a direct clinical usefulness, but a slight update of other pleural diseases has been also included. Among the main scientific advantages are included the thoracic ultrasonography, the intrapleural fibrinolytics, the pleurodesis agents, or the new pleural drainages techniques.

摘要

尽管在过去几年中,诊断或治疗方法发生了一些重要变化,但胸腔积液仍然是呼吸专科医生必须经常评估的疾病之一。本文的目的是更新有关胸腔积液的知识,而不是详尽地回顾胸膜疾病的病因。这些建议对具有直接临床实用性的主题有更广泛的延伸,但也包括了其他胸膜疾病的一些轻微更新。主要的科学优势包括胸部超声检查、胸膜内纤维蛋白溶解剂、胸膜固定剂或新的胸腔引流技术。

相似文献

1
Recommendations of diagnosis and treatment of pleural effusion. Update.胸腔积液的诊断与治疗建议。更新版。
Arch Bronconeumol. 2014 Jun;50(6):235-49. doi: 10.1016/j.arbres.2014.01.016. Epub 2014 Mar 31.
2
[Pay more attention to basic and clinical study for pleural effusions].[更加关注胸腔积液的基础与临床研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 May;36(5):323-4.
3
Pleural effusions.胸腔积液。
Med Clin North Am. 2011 Nov;95(6):1055-70. doi: 10.1016/j.mcna.2011.08.005. Epub 2011 Sep 25.
4
[Role of C-C chemokines in the determination of pleural effusion etiology].[C-C趋化因子在胸腔积液病因判定中的作用]
Pneumonol Alergol Pol. 2008;76(6):415-20.
5
[Contribution of pleural fluid analysis to the diagnosis of pleural effusion].[胸腔积液分析对胸腔积液诊断的贡献]
Med Clin (Barc). 2015 Aug 21;145(4):171-7. doi: 10.1016/j.medcli.2014.08.005. Epub 2014 Nov 27.
6
Diagnostic value of cholesterol in pleural effusions.胆固醇在胸腔积液中的诊断价值。
J Assoc Physicians India. 1995 Nov;43(11):748-50.
7
Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.胸腔积液中C反应蛋白在胸腔积液实验室诊断中的应用。
Eur J Med. 1992 Jul-Aug;1(4):201-7.
8
[The diagnostic usefulness of cholinesterase in pleural exudates].[胆碱酯酶在胸腔积液中的诊断价值]
Rev Clin Esp. 1997 Jun;197(6):402-5.
9
Management of Parapneumonic Pleural Effusion in Adults.成人脓胸性胸腔积液的处理。
Arch Bronconeumol. 2015 Dec;51(12):637-46. doi: 10.1016/j.arbres.2015.01.009. Epub 2015 Mar 26.
10
[Parapneumonic pleural effusion: difficulties in making therapeutic decisions].[肺炎旁胸腔积液:治疗决策的难点]
Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):44-8.

引用本文的文献

1
A Rare Case of Pleural Melanoma Masquerading as a Tubercular Pleural Effusion.一例伪装成结核性胸腔积液的胸膜黑色素瘤罕见病例。
Cureus. 2025 Aug 10;17(8):e89742. doi: 10.7759/cureus.89742. eCollection 2025 Aug.
2
A scoring model based on the pleural effusion adenosine deaminase-to-serum C-reactive protein ratio for differentiating tuberculous pleural effusion from non-tuberculous benign pleural effusion.一种基于胸腔积液腺苷脱氨酶与血清C反应蛋白比值的评分模型,用于鉴别结核性胸腔积液与非结核性良性胸腔积液。
BMC Pulm Med. 2025 Mar 28;25(1):139. doi: 10.1186/s12890-025-03593-1.
3
Biological and cytological-morphological assessment of tuberculous pleural effusions.
结核性胸腔积液的生物学及细胞形态学评估
Rom J Morphol Embryol. 2024 Oct-Dec;65(4):693-712. doi: 10.47162/RJME.65.4.17.
4
Complement C1q is a key player in tumor-associated macrophage-mediated CD8 T cell and NK cell dysfunction in malignant pleural effusion.补体C1q是恶性胸腔积液中肿瘤相关巨噬细胞介导的CD8 T细胞和NK细胞功能障碍的关键因素。
Int J Biol Sci. 2024 Nov 4;20(15):5979-5998. doi: 10.7150/ijbs.100607. eCollection 2024.
5
Performance verification of a biochemical detection system for hydrothorax and ascites and clinical diagnostic accuracy evaluation of exudate and tuberculous effusion.胸腔积液和腹水生化检测系统的性能验证及渗出液与结核性积液的临床诊断准确性评估
J Thorac Dis. 2024 May 31;16(5):3350-3360. doi: 10.21037/jtd-24-345. Epub 2024 May 20.
6
Benefit of intrapleural fibrinolytic therapy in the treatment of complicated parapneumonic effusion and empyema.胸腔内纤维蛋白溶解疗法在治疗复杂性类肺炎性胸腔积液和脓胸中的益处。
Pan Afr Med J. 2024 Feb 8;47:54. doi: 10.11604/pamj.2024.47.54.15439. eCollection 2024.
7
Biomarkers for distinguishing tuberculous pleural effusion from non-tuberculosis effusion: a retrospective study.鉴别结核性胸腔积液与非结核性胸腔积液的生物标志物:一项回顾性研究。
BMC Infect Dis. 2023 Nov 8;23(1):771. doi: 10.1186/s12879-023-08781-0.
8
[Risk and Mortality Factors for Pleural Effusions Requiring Diagnostic Thoracentesis].[需要诊断性胸腔穿刺术的胸腔积液的风险和死亡因素]
Open Respir Arch. 2022 Sep 6;4(4):100201. doi: 10.1016/j.opresp.2022.100201. eCollection 2022 Oct-Dec.
9
A scoring model for diagnosis of tuberculous pleural effusion.结核性胸腔积液诊断的评分模型。
BMC Pulm Med. 2022 Sep 2;22(1):332. doi: 10.1186/s12890-022-02131-7.
10
Development and validation of a prediction model for tuberculous pleural effusion: a large cohort study and external validation.结核性胸腔积液预测模型的建立与验证:一项大样本队列研究及外部验证。
Respir Res. 2022 May 27;23(1):134. doi: 10.1186/s12931-022-02051-4.